ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,021.91
0.37%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) Noticias

GNMX

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GNMX
FechaHoraFuenteTítuloSímboloCompañía
14/02/202015:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202009:57Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202005:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202014:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202014:42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202014:40Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202011:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202011:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202011:57Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202015:32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202015:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202015:15GlobeNewswire Inc.Cerecor and Aevi Genomic Medicine Complete MergerNASDAQ:GNMXAevi Genomic Medicine Inc
06/01/202015:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GNMXAevi Genomic Medicine Inc
31/12/201915:47Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:GNMXAevi Genomic Medicine Inc
23/12/201906:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GNMXAevi Genomic Medicine Inc
16/12/201906:30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNASDAQ:GNMXAevi Genomic Medicine Inc
11/12/201905:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/12/201907:45GlobeNewswire Inc.Cerecor to Acquire Aevi Genomic MedicineNASDAQ:GNMXAevi Genomic Medicine Inc
14/11/201907:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNMXAevi Genomic Medicine Inc
15/10/201907:00PR Newswire (US)Aevi Genomic Medicine, Inc. Receives Positive Nasdaq Listing DeterminationNASDAQ:GNMXAevi Genomic Medicine Inc
07/08/201907:00PR Newswire (US)Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 AntibodyNASDAQ:GNMXAevi Genomic Medicine Inc
07/08/201905:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
06/08/201916:12Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:GNMXAevi Genomic Medicine Inc
06/08/201907:00PR Newswire (US)Aevi Genomic Medicine to Present at the 2019 Wedbush PacGrow Healthcare ConferenceNASDAQ:GNMXAevi Genomic Medicine Inc
26/07/201916:19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
15/07/201915:05PR Newswire (US)Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Gener...NASDAQ:GNMXAevi Genomic Medicine Inc
30/04/201907:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNMXAevi Genomic Medicine Inc
29/03/201916:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/201907:25GlobeNewswire Inc.Factors of Influence in 2019, Key Indicators and Opportunity within Park Hotels & Resorts, Planet Fitness, Aevi Genomic Medic...NASDAQ:GNMXAevi Genomic Medicine Inc
02/01/201915:30PR Newswire (US)Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children w...NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

Su Consulta Reciente

EU
C575S
C575S
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados